Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-06

Clinical Trial Update: Combined Theta-gamma STN Stimulation for Verbal Fluency in Parkinson Disease [NA]

View source ↗

Summary

The study evaluating combined theta-gamma subthalamic nucleus stimulation to improve verbal fluency in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Turin, Italy | Conditions: Parkinson Disease | NA | Status: COMPLETED